DOSE FINDING PROSPECTIVE ANALYSIS AFTER HEART SURGERY for Sucrosomial Iron
ConditionAnemia
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorCardiochirurgia E.H.
About this trial
Randomization to different doses of Sucrosomial Iron for one moth after discharge to rehab after heart surgery to assess if more iron grants a faster recovery or not
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Hb>11.1, hematological primary disesases
Trial design
Design model
Parallel
Treatments tested in this trial
Sucrosomial Iron
DrugSideral Forte, Italian market formulation of Sucrosomila Iron 30mg per cp
Treatment groups
150 Participants
are divided into 3 treatment groupsGroup A: 30mgExperimental treatment 1 intervention
Group B: 60mgExperimental treatment 1 intervention
Group C: 120mgExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Hemoglobin
Hemoglobin level at 30 day of treatment
Time frame
30 daysSecondary outcomes
1
Martial Metabolism
Ferritin, Transferrin, Iron Saturation
Time frame
30 daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: